Searched for
GSK S HIV
GSK launches $2.5 bln buyback, lifts sales target after stellar Q4GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, bett...05 Feb, 2025, 07.34 PM IST- GSK CEO Emma Walmsley's total pay rises 51% to nearly 13 mln pounds in 2023GSK CEO Emma Walmsley's total remuneration rose 51% to 12.7 million pounds ($16 million) in 2023, driven by a significant increase in perfo...01 Mar, 2024, 10.55 PM IST
- European Commission authorises GSK's HIV prevention drugCabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually-acqu...19 Sep, 2023, 12.22 PM IST
- Aurobindo, Cipla, Viatris in licensing pact with MPP to make ViiV's HIV preventive therapyThrough the MPP-ViiV Healthcare agreement, the three generic manufacturers will be able to develop, manufacture, and supply generic version...30 Mar, 2023, 06.53 PM IST
- Pharma Industry staring at 30-40 bps hit on updated NLEMManchanda added that the anti-infectives treating HIV, TB and drug cessation treatments in the list doesn't have a major impact on margins ...15 Sep, 2022, 12.00 AM IST
- GSK to boost spending power of pharma business post break-upGlaxoSmithKline will lay out plans to boost the spending power of its research-focused pharmaceuticals business at an investor day. GSK's s...21 Jun, 2021, 05.04 PM IST
- GSK, Sanofi say COVID-19 shot won't be ready until late 2021The companies said early trials showed the vaccine produced an "insufficient" immune response in older adults, demonstrating the need to re...11 Dec, 2020, 05.24 PM IST
- GSK's tuberculosis vaccine shows promising resultsThe new vaccine, known as M72/AS01E, was tested at 11 sites in Kenya, South Africa and Zambia in adults whose blood tests showed they had l...29 Oct, 2019, 01.40 PM IST
- Stocks in the news: Vedanta, Laurus Labs, Xelpmoc Design, Zee Entertainment, DHFL and NIIT TechHere are a few stocks which may buzz the most in today's trade.04 Feb, 2019, 08.39 AM IST
- Activists cry foul over new HIV drug monopolyOnly one Indian drug maker, Emcure, will be allowed to sell the medicine in the Indian private market, because of a licensing agreement wit...27 Dec, 2016, 01.10 AM IST
- GSK Healthcare banks on Sensodyne, Crocin to drive growth in IndiaIn India, the power brands will be Sensodyne, Panadol (called Crocin in India), nasal decongestant Otrivin and Voltaren pain relieving gels...07 Apr, 2016, 06.24 PM IST
- Europe backs new dual-action Novartis lung drugNovartis won an important endorsement of its new medicine for chronic lung disease when European regulators recommended approval of Ultibro...26 Jul, 2013, 06.14 PM IST
- Glaxo takes new AIDS drug into final-stage testsGlaxoSmithKline and its partner Shionogi are progressing a new drug against HIV into final-stage clinical testing, ramping up competition i...21 Jul, 2010, 02.37 PM IST
- GlaxoSmithKline buys US skincare firm Stiefel for $3.6 bnBritish drugs firm GlaxoSmithKline (GSK) said Monday it will buy Stiefel Laboratories, US maker of anti-itching creams, acne treatments and...21 Apr, 2009, 12.27 AM IST
- German firm denied AIDS drug patentThe Delhi patent office has rejected German pharma major Boehringer Ingelheim’s product patent application for its paediatric form of the a...20 Jun, 2008, 12.50 AM IST
- GSK drops claims on two AIDS medicinesIn a relief to around 2.5 million HIV patients and generic firms like Cipla and Ranbaxy, GlaxosmithKline (GSK) has pulled out the patent ap...07 Dec, 2007, 01.11 AM IST
- GSK withdraws patent application for AIDS drugGlobal pharmaceutical major GlaxoSmithKline (GSK) has withdrawn its patent application in India for anti-AIDS drug Combivir, which has been...21 Aug, 2006, 02.40 PM IST
Load More
